These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 37344566)

  • 21. Age-related cognitive decline in baboons: modeling the prodromal phase of Alzheimer's disease and related dementias.
    Lizarraga S; Daadi EW; Roy-Choudhury G; Daadi MM
    Aging (Albany NY); 2020 May; 12(11):10099-10116. PubMed ID: 32427127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
    Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
    Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
    Jellinger KA
    J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease.
    Ameen-Ali KE; Wharton SB; Simpson JE; Heath PR; Sharp P; Berwick J
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):553-570. PubMed ID: 28880417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part V: why is Ca2+ signal lower in the disease?
    Chen M; Fernandez HL
    Front Biosci; 1999 Apr; 4():A9-15. PubMed ID: 10099137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective.
    Rajah Kumaran K; Yunusa S; Perimal E; Wahab H; Müller CP; Hassan Z
    J Alzheimers Dis; 2023; 91(2):507-530. PubMed ID: 36502321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease.
    Kukreja L; Kujoth GC; Prolla TA; Van Leuven F; Vassar R
    Mol Neurodegener; 2014 May; 9():16. PubMed ID: 24885175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.
    Frost JL; Le KX; Cynis H; Ekpo E; Kleinschmidt M; Palmour RM; Ervin FR; Snigdha S; Cotman CW; Saido TC; Vassar RJ; St George-Hyslop P; Ikezu T; Schilling S; Demuth HU; Lemere CA
    Am J Pathol; 2013 Aug; 183(2):369-81. PubMed ID: 23747948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.
    Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM
    Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 2-process model for neuropathology of Alzheimer's disease.
    Mungas D; Tractenberg R; Schneider JA; Crane PK; Bennett DA
    Neurobiol Aging; 2014 Feb; 35(2):301-8. PubMed ID: 24080173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural networks in Alzheimer's disease.
    Reid AT; Evans AC
    Eur Neuropsychopharmacol; 2013 Jan; 23(1):63-77. PubMed ID: 23294972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liraglutide Protects Against Brain Amyloid-β
    Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
    Baazaoui N; Flory M; Iqbal K
    J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.
    Koronyo-Hamaoui M; Koronyo Y; Ljubimov AV; Miller CA; Ko MK; Black KL; Schwartz M; Farkas DL
    Neuroimage; 2011 Jan; 54 Suppl 1():S204-17. PubMed ID: 20550967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease.
    Go J; Chang DH; Ryu YK; Park HY; Lee IB; Noh JR; Hwang DY; Kim BC; Kim KS; Lee CH
    Nutr Res; 2021 Feb; 86():96-108. PubMed ID: 33551257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer's Disease].
    Lysikova EA; Kuzubova EV; Radchenko AI; Patrakhanov EA; Chaprov KD; Korokin MV; Deykin AV; Gudyrev OS; Pokrovskii MV
    Mol Biol (Mosk); 2023; 57(1):85-94. PubMed ID: 36976741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.
    Morris JC; Price JL
    J Mol Neurosci; 2001 Oct; 17(2):101-18. PubMed ID: 11816784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
    Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
    Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.